Joslin Diabetes Grand Rounds - Dyslipidemia and Diabetes
Dyslipidemia and Diabetes: Evolving Guidelines, Treatments, Goals
Speakers: Michael Rocco, MD, Medical Director of Stress Testing and Cardiac Rehabilitation
Richard Beaser, MD, Senior Physician, Medical Director, Professional Education
Om P. Ganda, MD, Medical Director of the Lipid Clinic, Chair of the Clinical Oversight Committee
Duration: 60 minutes
Presented on: March 29, 2017
Michael Rocco, MD
Michael Rocco, MD
Medical Director of Stress Testing and Cardiac RehabilitationMichael Rocco, MD, is medical director of Cardiac Rehabilitation and Stress Testing, section of preventive cardiology, and a staff physician in the Departments of Cardiovascular Medicine and Molecular and Functional Imaging in the Division of Radiology at Cleveland Clinic in Ohio. His clinical research focuses primarily on the prognostic significance of asymptomatic ischemia, the evaluation of therapeutic interventions and exercise in the treatment and prevention of coronary artery disease, and the effect of drug therapy on lowering lipid levels. Dr Rocco lectures regionally and nationally, has published articles and abstracts in leading medical journals, and has authored chapters in textbooks. He received his medical degree from Duke University Medical Center in Durham, North Carolina.
Richard Beaser, MD
Richard Beaser, MD
Senior Physician, Medical Director, Professional EducationRichard S. Beaser, M.D., is a practicing physician in the Joslin Clinic and holds the position of Associate Clinical Professor of Medicine at Harvard Medical School. He has also been the Medical Executive Director of Professional Education at Joslin and was instrumental in developing that activity at Joslin, a department he founded in 1990. Dr. Beaser graduated in 1973 from Trinity College, Hartford, and received his medical degree from Boston University School of Medicine in 1977. He served as a resident in internal medicine at the University of Massachusetts Medical Center in Worcester from 1977-1980. He was a fellow in endocrinology at the Joslin Diabetes Center, Boston, MA 1980-81, and in Endocrinology at the Lahey Clinic Medical Center, Burlington, MA 1981-82. Dr. Beaser has been on the staff of the Joslin Diabetes Center since 1982. He has held numerous past positions at Joslin, including Section Chief of the Adult Diabetology Practice, Medical Director of the Diabetes Treatment Unit, Coordinator of the Patient Education Section, and Medical Director of Joslin TrialNet, a clinical trials network. He has been a clinical research investigator, including the landmark Diabetes Control and Complications Trial. Dr. Beaser has authored 4 books: Joslin Diabetes Manual, Outsmarting Diabetes, The Joslin Guide to Diabetes, and Joslin’s Diabetes Deskbook: A Guide for Primary Care Providers. Dr Beaser is a well-known national lecturer on clinical diabetes and its comorbidities. He is the author of numerous publications in peer review journals, review articles, and book chapters. In his role as Medical Executive Director of Professional Education at Joslin Diabetes Center, and currently as the Chair of the CME Committee, Dr. Beaser has a specific focus on development or oversight of educational content for the department, targeting physicians, other medical professionals, and patients. He leads departmental conceptualization and development of projects and activities.
Om P. Ganda, MD
Om P. Ganda, MD
Medical Director of the Lipid Clinic, Chair of the Clinical Oversight CommitteeOm P. Ganda, MD, FACE, is a board-certified specialist in internal medicine, endocrinology and metabolism, and clinical nutrition. He is a senior physician at the Joslin Diabetes Center and an associate professor of medicine at Harvard Medical School in Boston, Massachusetts. A co-investigator in the Diabetes Control and Complications Trial (DCCT), he has been engaged in clinical diabetes research for more than 3 decades. He is co-investigator of Epidemiology of Diabetes Interventions and Complications (EDIC), an ongoing, long-term, follow-up study. In addition to his clinical research and teaching, he directs the Lipid Clinic at Joslin, where he treats complex patients with dyslipidemia. Dr Ganda received his MD from the SMS Medical College, University of Rajasthan, Jaipur, India.
Dyslipidemia and Diabetes: Evolving Guidelines, Treatments, Goals
Jointly provided by Primary Care Network and PlatformQ Health Education, LLC
ACCREDITATION STATEMENT This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Primary Care Network and PlatformQ Health Education, LLC. Primary Care Network is accredited by the ACCME to provide continuing medical education for physicians.
CREDIT DESIGNATION STATEMENTS Live Online Activity Primary Care Network designates each live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Online On-Demand Enduring Material Primary Care Network designates each enduring activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
All other healthcare professionals will be issued a certificate of participation.
Primary Care Network has been awarded Accreditation with Commendation (2013-2019) by the Accreditation Council for Continuing Medical Education (ACCME).
DATE OF RELEASE/EXPIRATION Live Online Activity Wednesday March 29, 2017 from 12:00 – 1:00PM EDT.
Enduring Material The enduring material will be available from March 29, 2017 – September 29, 2017.
LEARNING OBJECTIVES At the conclusion of this activity, participants will be able to:
• Implement key elements and majorchanges in the updated treatment guidelines for dyslipidemia with a focus on how they would apply to treatment design for dyslipidemia and diabetes • Identify when newer non-statin drug therapies may be indicated for patients with high lipid-related CVD risk despite maximum tolerated statin therapy • Delineate the pharmacology, approved indications, and potential barriers to overcome ineffective use of PCSK9 inhibitors in patients at high risk for CVD events
TARGET AUDIENCE This activity is intended for primary care clinicians and other health care providers, such as cardiologists and nephrologists, who provide frontline glycemic management for type 2 diabetes and related conditions, as well as clinically–focused diabetologists and endocrinologists; diabetes educators, and other non-MD health care providers involved in the diagnosis, treatment, education, and management of patients with T2DM, including other medical practice support staff who interact with people who have diabetes (RNs, LPNs, medical office assistants).
ACKNOWLEDGEMENT OF COMMERCIAL SUPPORT This activity is supported by an educational funding donation provided by Amgen.
METHOD OF PARTICIPATION There are no fees to participate in this activity. To participate in the activity, go to http://www.diabetesserieslive.com/. To receive credit, participants must (1) read the target audience, learning objectives, and disclosure statements, (2) complete the educational activity online, and (3) complete the pre and post-test and activity evaluation. Participants must receive a minimum score of 70% on the post-test in order to receive a certificate.
HARDWARE/SOFTWARE REQUIREMENTS Participants will need a computer with a recent version of Adobe Flash installed, as well as an internet connection sufficient for streaming media.
STATEMENT OF DISCLOSURE AND INDEPENDENCE It is the policy of Primary Care Network (PCN) to ensure all of its accredited educational activities are planned, developed, and conducted in accordance with the Accreditation Council for Continuing Medical Education's (ACCME) Essential Areas and Policies. In accordance with ACCME requirements, PCN has Conflict of Interest (COI) and Disclosure Policies that are designed to ensure that PCN accredited educational activities are fair, balanced, independent, evidence based, and based on scientific rigor.
PCN's Resolution of Personal COI Policy aims to ensure that all potential conflicts are identified and resolved prior to the activity, content is developed and presented free of commercial bias, and is in the interest of promoting improvements or quality in healthcare. All individuals who are in a position to influence and/or control content of a PCN accredited Continuing Medical Education (CME) activity are considered Planning Committee Members. Planning Committee Members include individuals involved in a CME activity who may develop, edit, review and/or present content. Planning Committee Members are required to disclose to the participants any real or apparent conflict(s) of interest related to the activity. The educational content is also reviewed for independence and content validation by an independent clinical reviewer. Independence is also monitored through the activity and overall program evaluation process.
The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
Name of Faculty or Presenter Reported Relevant Financial Relationship: Richard Beaser, MD None Om P. Ganda, MD Medical Lectures: Merck & Co. Advisory Board: Novo Nordisk, Sanofi–Aventis Research/Grants Amarin Michael Rocco, MD None
The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
Name of Planner Reported Relevant Financial Relationship Brian Koffman, MDCM, DCFP, DABFM, MS Ed Primary Care Network CME Content Reviewer Advisory Board & Speaker's Bureau: Ironwood Pharmaceuticals Patient Speaker: Juno Therapeutics, Verastem
The following PCN planner and manager, Jill Hays, hereby state that she or her spouse/life partner do not have any relevant financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.
The following PlatformQ Health Education, LLC planner, Elizabeth del Nido, hereby states that she or her spouse/life partner do not have any relevant financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.
DISCLOSURE OF UNAPPROVED/OFF LABEL USE (if applicable): This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
DISCLAIMER: Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
The opinions, ideas, recommendations, and perspectives expressed in this activity are those of the program authors and presenting faculty only and do not necessarily reflect the opinions, ideas, recommendations or perspectives of their affiliated institutions, Primary Care Network, advisory boards or consultants.
CONTACT INFORMATION Accreditation Support: Please contact Primary Care Network at http://www.primarycarenetwork.org/.
Technical Support: For any technical issues or issues with your CME Certificate, please contact DiabetesSeriesLive at 877-394-1306 or at http://www.diabetesserieslive.com/